Emcure Pharmaceuticals Ltd (EMCURE) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.052x

Based on the latest financial reports, Emcure Pharmaceuticals Ltd (EMCURE) has a cash flow conversion efficiency ratio of 0.052x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.56 Billion ≈ $27.71 Million USD) by net assets (Rs48.84 Billion ≈ $528.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Emcure Pharmaceuticals Ltd - Cash Flow Conversion Efficiency Trend (2022–2025)

This chart illustrates how Emcure Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Emcure Pharmaceuticals Ltd total liabilities for a breakdown of total debt and financial obligations.

Emcure Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Emcure Pharmaceuticals Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Tian Di Science & Technology Co Ltd SHG:600582	0.005x
Schibsted ASA A OL:SCHA	0.011x
Shenzhen Yan Tian Port Holdings Co Ltd SHE:000088	0.008x
Changzheng Engineering Co Ltd SHG:603698	-0.046x
Americold Realty Trust NYSE:COLD	0.045x
First Interstate BancSystem Inc NASDAQ:FIBK	0.020x
Suzhou HYC Technology Co Ltd SHG:688001	0.057x
Shanghai Daimay Auto Interior SHG:603730	0.053x

Annual Cash Flow Conversion Efficiency for Emcure Pharmaceuticals Ltd (2022–2025)

The table below shows the annual cash flow conversion efficiency of Emcure Pharmaceuticals Ltd from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Emcure Pharmaceuticals Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs46.42 Billion ≈ $501.97 Million	Rs8.52 Billion ≈ $92.11 Million	0.183x	-47.79%
2024-03-31	Rs31.22 Billion ≈ $337.61 Million	Rs10.97 Billion ≈ $118.66 Million	0.351x	+24.70%
2023-03-31	Rs26.50 Billion ≈ $286.55 Million	Rs7.47 Billion ≈ $80.77 Million	0.282x	-22.43%
2022-03-31	Rs21.14 Billion ≈ $228.64 Million	Rs7.68 Billion ≈ $83.08 Million	0.363x	--

About Emcure Pharmaceuticals Ltd

NSE:EMCURE India Drug Manufacturers - Specialty & Generic

Market Cap

$3.44 Billion

Rs318.53 Billion INR

Market Cap Rank

#4543 Global

#194 in India

Share Price

Rs1680.10

Change (1 day)

-2.88%

52-Week Range

Rs1007.60 - Rs1729.90

All Time High

Rs1729.90